European experience and risk factor analysis of donor cell-derived leukaemias/MDS following haematopoietic cell transplantation.

MLA

Engel, Nicole, et al. “European Experience and Risk Factor Analysis of Donor Cell-Derived Leukaemias/MDS Following Haematopoietic Cell Transplantation.” Leukemia, vol. 33, no. 2, Feb. 2019, pp. 508–17. EBSCOhost, https://doi.org/10.1038/s41375-018-0218-6.

APA

Engel, N., Rovo, A., Badoglio, M., Labopin, M., Basak, G. W., Beguin, Y., Guyotat, D., Ljungman, P., Nagler, A., Schattenberg, A., Schroeder, T., Schroyens, W., Tischer, J., Socie, G., Kolb, H.-J., Tichelli, A., Salooja, N., & Duarte, R. F. (2019). European experience and risk factor analysis of donor cell-derived leukaemias/MDS following haematopoietic cell transplantation. Leukemia, 33(2), 508–517. https://doi.org/10.1038/s41375-018-0218-6

Chicago

Engel, Nicole, Alicia Rovo, Manuela Badoglio, Myriam Labopin, Grzegorz W Basak, Yves Beguin, Denis Guyotat, et al. 2019. “European Experience and Risk Factor Analysis of Donor Cell-Derived Leukaemias/MDS Following Haematopoietic Cell Transplantation.” Leukemia 33 (2): 508–17. doi:10.1038/s41375-018-0218-6.